In addition, higher expression of OGT, FOXC1, ASNS, GPT2, CBS, or FTH1 was also associated with poorer outcomes in clinical cases with renal clear cell carcinoma or glioma (Fig. S12). The gene discussed is FOXC1; the disease is glioma.